Board Meeting23 May 2026, 05:51 pm
Gujarat Kidney Board Meeting on May 28, 2026 to Approve Audited Results
AI Summary
Gujarat Kidney and Super Speciality Ltd has scheduled a Board of Directors meeting on May 28, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The meeting will also address variation in objects of IPO, conduct a postal ballot, and appoint a Chief Executive Officer (CEO). The trading window has been closed from April 1, 2026, until 48 hours after the announcement of the audited financial results.
Key Highlights
- Board meeting scheduled for May 28, 2026, to approve audited financial results.
- The board will consider standalone and consolidated results for Q4 and FY26.
- Appointment of CEO and variation in IPO objects are also on the agenda.
- Trading window closed from April 1, 2026, until 48 hours post results announcement.
Price Impact
More from GKSL